Patents by Inventor Agnes H. Chan

Agnes H. Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11472832
    Abstract: Provided herein are synthetic analogs of withanolide natural products and their pharmaceutical uses in treating neurodegenerative diseases.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: October 18, 2022
    Assignees: ARNA Therapeutics Inc., Universite Laval
    Inventors: Anthony A. Shaw, Jean-Pierre Julien, Agnes H. Chan
  • Publication number: 20200325168
    Abstract: Provided herein are synthetic analogs of withanolide natural products and their pharmaceutical uses in treating neurodegenerative diseases.
    Type: Application
    Filed: June 21, 2019
    Publication date: October 15, 2020
    Inventors: Anthony A. Shaw, Jean-Pierre Julien, Agnes H. Chan
  • Publication number: 20190315798
    Abstract: Provided herein are synthetic analogs of withanolide natural products and their pharmaceutical uses in treating neurodegenerative diseases.
    Type: Application
    Filed: June 21, 2019
    Publication date: October 17, 2019
    Inventors: Anthony A. Shaw, Jean-Pierre Julien, Agnes H. Chan
  • Patent number: 10351590
    Abstract: Provided herein are synthetic analogs of withanolide natural products of formula (I), wherein R1-R4 are as defined herein, and their pharmaceutical uses in treating neurodegenerative diseases.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: July 16, 2019
    Assignees: Imstar Therapeutics Inc., Universite Laval
    Inventors: Anthony A. Shaw, Jean-Pierre Julien, Agnes H. Chan
  • Publication number: 20170022247
    Abstract: Provided herein are synthetic analogs of withanolide natural products of formula (I), wherein R1-R4 are as defined herein, and their pharmaceutical uses in treating neurodegenerative diseases.
    Type: Application
    Filed: November 25, 2014
    Publication date: January 26, 2017
    Inventors: Anthony A. Shaw, Jean-Pierre Julien, Agnes H. Chan
  • Publication number: 20040110731
    Abstract: The present invention relates to a method of treating non-melanoma skin cancer comprising: (a) intravenously administering a porphyrin based photosensitizer to a subject with non-melanoma skin cancer; (b) irradiating one or more tumors and a circumferential peritumoral margin of at least 1 mm with a light at a wavelength absorbed by said photosensitzer; wherein the irradiating step delivers a light dose of 180 J/cm2. It has been found that the above treatment gives extremely good efficacy while having a surprisingly good cosmetic outcome.
    Type: Application
    Filed: December 4, 2002
    Publication date: June 10, 2004
    Inventors: Agnes H. Chan, Herma C. Neyndorff
  • Patent number: 6201870
    Abstract: A pseudorandom sequence generator including a first feedback shift register having at least one input and at least one output and a first controller having an output in communication with the at least one input of the first feedback shift register; the first feedback shift register operating at a first speed S1 and the first controller operating at a second speed S2. In one embodiment the first speed S1 of the first feedback shift register is an integer multiple of the second speed S2 of the first controller. In another embodiment the first feedback shift register includes a shift register having an input, an output, and at least one tap; and a feedback function generator having a first input in communication with the at least one tap of the shift register, a second input in communication with the output of the first controller, and an output in communication with the input of the shift register; the feedback function generator includes at least one feedback function.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: March 13, 2001
    Assignees: Massachusetts Institue of Technology, Northeastern University
    Inventors: Muriel Medard, John D. Moores, Katherine L. Hall, Kristin A. Rauschenbach, Salil Parikh, Agnes H. Chan
  • Patent number: 6107325
    Abstract: Green porphyrins act as antigen-specific immunomodulators in the active phase of an immune response to a particular antigen. This effect occurs at ambient light levels.
    Type: Grant
    Filed: May 18, 1998
    Date of Patent: August 22, 2000
    Assignees: QLT PhotoTherapeutics, Inc., The University of British Columbia
    Inventors: Agnes H. Chan, David W. C. Hunt, Julia G. Levy, Modestus O. K. Obochi, Anna M. Richter, Guillermo O. Simkin
  • Patent number: 6096776
    Abstract: Green porphyrins act as antigen-specific immunomodulators in the active phase of an immune response to a particular antigen, as well as to interfere with intercellular communication. These effects occur in the absence of radiation absorbed by the green porphyrin.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: August 1, 2000
    Assignees: QLT PhotoTherapeutics, Inc., The University of British Columbia
    Inventors: Agnes H. Chan, David W. C. Hunt, Julia G. Levy, Modestus O. K. Obochi, Anna M. Richter, Guillermo O. Simkin
  • Patent number: 6008241
    Abstract: Green porphyrins act as antigen-specific immunomodulators in the active phase of an immune response to a particular antigen. This effect occurs at ambient light levels.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: December 28, 1999
    Assignee: QLT PhotoTherapeutics, Inc.
    Inventors: Agnes H. Chan, David W. C. Hunt, Julia G. Levy, Modestus O. K. Obochi, Anna M. Richter, Guillermo O. Simkin